BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: El-Hayek G, Bangalore S, Casso Dominguez A, Devireddy C, Jaber W, Kumar G, Mavromatis K, Tamis-Holland J, Samady H. Meta-Analysis of Randomized Clinical Trials Comparing Biodegradable Polymer Drug-Eluting Stent to Second-Generation Durable Polymer Drug-Eluting Stents. JACC Cardiovasc Interv 2017;10:462-73. [PMID: 28279314 DOI: 10.1016/j.jcin.2016.12.002] [Cited by in Crossref: 94] [Cited by in F6Publishing: 54] [Article Influence: 23.5] [Reference Citation Analysis]
Number Citing Articles
1 Adepu S, Luo H, Ramakrishna S. Heparin-Tagged PLA-PEG Copolymer-Encapsulated Biochanin A-Loaded (Mg/Al) LDH Nanoparticles Recommended for Non-Thrombogenic and Anti-Proliferative Stent Coating. Int J Mol Sci 2021;22:5433. [PMID: 34063962 DOI: 10.3390/ijms22115433] [Reference Citation Analysis]
2 Kereiakes DJ, Windecker S, Jobe RL, Mehta SR, Sarembock IJ, Feldman RL, Stein B, Dubois C, Grady T, Saito S, Kimura T, Underwood P, Allocco DJ, Meredith IT. Clinical Outcomes Following Implantation of Thin-Strut, Bioabsorbable Polymer-Coated, Everolimus-Eluting SYNERGY Stents: Final 5-Year Results of the EVOLVE II Randomized Trial. Circ: Cardiovascular Interventions 2019;12. [DOI: 10.1161/circinterventions.119.008152] [Cited by in Crossref: 22] [Cited by in F6Publishing: 3] [Article Influence: 11.0] [Reference Citation Analysis]
3 Iglesias JF, Roffi M, Degrauwe S, Secco GG, Aminian A, Windecker S, Pilgrim T. Orsiro cobalt-chromium sirolimus-eluting stent: present and future perspectives. Expert Review of Medical Devices 2017;14:773-88. [DOI: 10.1080/17434440.2017.1378091] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
4 Strobel HA, Qendro EI, Alsberg E, Rolle MW. Targeted Delivery of Bioactive Molecules for Vascular Intervention and Tissue Engineering. Front Pharmacol 2018;9:1329. [PMID: 30519186 DOI: 10.3389/fphar.2018.01329] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
5 Buiten RA, Ploumen EH, Zocca P, Doggen CJM, van der Heijden LC, Kok MM, Danse PW, Schotborgh CE, Scholte M, de Man FHAF, Linssen GCM, von Birgelen C. Outcomes in Patients Treated With Thin-Strut, Very Thin-Strut, or Ultrathin-Strut Drug-Eluting Stents in Small Coronary Vessels: A Prespecified Analysis of the Randomized BIO-RESORT Trial. JAMA Cardiol 2019;4:659-69. [PMID: 31111862 DOI: 10.1001/jamacardio.2019.1776] [Cited by in Crossref: 29] [Cited by in F6Publishing: 11] [Article Influence: 29.0] [Reference Citation Analysis]
6 Pal N, Din J, O'Kane P. Contemporary Management of Stent Failure: Part One. Interv Cardiol 2019;14:10-6. [PMID: 30858886 DOI: 10.15420/icr.2018.39.1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
7 Nogic J, Thein P, Mirzaee S, Comella A, Soon K, Cameron JD, West NEJ, Brown AJ. Biodegradable-Polymer Versus Polymer-Free Drug-Eluting Stents for the Treatment of Coronary Artery Disease. Cardiovasc Revasc Med 2019;20:865-70. [PMID: 30578169 DOI: 10.1016/j.carrev.2018.12.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
8 Buccheri S, James S, Lindholm D, Fröbert O, Olivecrona GK, Persson J, Hambraeus K, Witt N, Erlinge D, Angerås O, Lagerqvist B, Sarno G. Clinical and angiographic outcomes of bioabsorbable vs. permanent polymer drug-eluting stents in Sweden: a report from the Swedish Coronary and Angioplasty Registry (SCAAR). European Heart Journal 2019;40:2607-15. [DOI: 10.1093/eurheartj/ehz244] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
9 Shah R, Rao SV, Latham SB, Kandzari DE. Efficacy and Safety of Drug-Eluting Stents Optimized for Biocompatibility vs Bare-Metal Stents With a Single Month of Dual Antiplatelet Therapy: A Meta-analysis. JAMA Cardiol 2018;3:1050-9. [PMID: 30383145 DOI: 10.1001/jamacardio.2018.3551] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
10 Azzalini L, Demir OM, Gasparini GL, Grancini L, La Manna A, Ojeda S, Benincasa S, Bellini B, Poletti E, Maccagni D, Soldi M, Iannetta L, Trabattoni D, Gravina G, Hidalgo F, Giannini F, Pan M, Tamburino C, Bartorelli AL, Reimers B, Godino C, Carlino M, Colombo A. Outcomes of a novel thin-strut bioresorbable-polymer sirolimus-eluting stent in patients with chronic total occlusions: A multicenter registry. International Journal of Cardiology 2018;258:36-41. [DOI: 10.1016/j.ijcard.2018.01.115] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Tang XF, Ma YL, Song Y, Xu JJ, Yao Y, He C, Wang HH, Jiang P, Jiang L, Liu R, Gao Z, Zhao XY, Qiao SB, Yang YJ, Gao RL, Xu B, Yuan JQ. Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study. Cardiovasc Diabetol 2018;17:114. [PMID: 30107794 DOI: 10.1186/s12933-018-0758-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
12 Rao G, Sheth S, Grines C. Percutaneous coronary intervention: 2017 in review. J Interven Cardiol 2018;31:117-28. [DOI: 10.1111/joic.12508] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Spione F, Brugaletta S. Second generation drug-eluting stents: a focus on safety and efficacy of current devices. Expert Rev Cardiovasc Ther 2021;19:107-27. [PMID: 33417509 DOI: 10.1080/14779072.2021.1874352] [Reference Citation Analysis]
14 Sakamoto A, Jinnouchi H, Torii S, Virmani R, Finn AV. Understanding the Impact of Stent and Scaffold Material and Strut Design on Coronary Artery Thrombosis from the Basic and Clinical Points of View. Bioengineering (Basel) 2018;5:E71. [PMID: 30181463 DOI: 10.3390/bioengineering5030071] [Cited by in Crossref: 29] [Cited by in F6Publishing: 16] [Article Influence: 9.7] [Reference Citation Analysis]
15 Tsai ML, Hsieh MJ, Chen CC, Chang SH, Wang CY, Chen DY, Yang CH, Yeh JK, Ho MY, Hsieh IC. Comparison of 9-Month Angiographic Follow-Up and Long-Term Clinical Outcomes of Biodegradable Polymer Drug-Eluting Stents and Second-Generation Durable Polymer Drug-Eluting Stents in Patients Undergoing Single Coronary Artery Stenting. Acta Cardiol Sin 2020;36:97-104. [PMID: 32201459 DOI: 10.6515/ACS.202003_36(2).20190729A] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
16 Kim MC, Kim IS, Jeong MH, Sim DS, Hong YJ, Kim JH, Ahn Y, Cho JG, Park JC. Incidence of cardiac death and recurrent stent thrombosis after treatment for angiographically confirmed stent thrombosis. J Cardiol 2019;74:267-72. [PMID: 30955998 DOI: 10.1016/j.jjcc.2019.02.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
17 Davenport ED, Syburra T, Gray G, Rienks R, Bron D, Manen O, d'Arcy J, Guettler NJ, Nicol ED. Management of established coronary artery disease in aircrew with previous myocardial infarction or revascularisation. Heart 2019;105:s31-7. [PMID: 30425084 DOI: 10.1136/heartjnl-2018-313055] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
18 Nogic J, Mccormick LM, Francis R, Nerlekar N, Jaworski C, West NE, Brown AJ. Novel bioabsorbable polymer and polymer-free metallic drug-eluting stents. Journal of Cardiology 2018;71:435-43. [DOI: 10.1016/j.jjcc.2017.12.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
19 Nappi F, Nenna A, Larobina D, Martuscelli G, Singh SSA, Chello M, Ambrosio L. The Use of Bioactive Polymers for Intervention and Tissue Engineering: The New Frontier for Cardiovascular Therapy. Polymers (Basel) 2021;13:446. [PMID: 33573282 DOI: 10.3390/polym13030446] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
20 Gori T. Vascular Wall Reactions to Coronary Stents-Clinical Implications for Stent Failure. Life (Basel) 2021;11:63. [PMID: 33477361 DOI: 10.3390/life11010063] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
21 Vranckx P, Valgimigli M, Jüni P, Hamm C, Steg PG, Heg D, van Es GA, Mcfadden EP, Onuma Y, van Meijeren C, Chichareon P, Benit E, Möllmann H, Janssens L, Ferrario M, Moschovitis A, Zurakowski A, Dominici M, Van Geuns RJ, Huber K, Slagboom T, Serruys PW, Windecker S, Abdellaoui M, Adlam D, Akin I, Albarran Gonzalez-trevilla A, Almeida M, Alves Lemos Neto P, Aminian A, Anderson R, Andreae R, Angioi M, Asano T, Barbato E, Barlis P, Barraud P, Benit E, Bertrand O, Beygui F, Bolognese L, Botelho R, Bouwman C, Bressers M, Brunel P, Buszman P, Buysschaert I, Canas da Silva P, Carrie D, Cequier A, Chichareon P, Chin Chang C, Chowdhary S, Collet C, Colombo A, Cotton J, Cruz Ferreira R, Curello S, Curzen N, de Bot J, de Vreede T, Delle Karth G, Dijksma L, Dominici M, Édes I, Eeckhout E, Eitel I, Faluközy J, Fath-ordoubadi F, Ferrario M, Fontos G, Francisco Diaz J, Freitas Quintella E, Frey B, Friedrich G, Galasko G, Galuszka G, Gama Ribeiro V, Garg S, Gargiulo G, Geisler T, Gelev V, Ghandilyan A, Goicolea J, Gori T, Gragnano F, Guimarães A, Hamm C, Haude M, Heg D, Heijke P, Hernández Antolin RA, Hildick-smith D, Hillen D, Hoekman I, Hofma S, Holmvang L, Hoole S, Horváth I, Huber K, Hugense A, Ibrahim K, Iñiguez A, Isaaz K, Jambrik Z, Janssens L, Jasionowicz P, Jonk J, Jung W, Jüni P, Katagiri Y, Kogame N, Koh TH, Koning R, Konteva M, Kőszegi Z, Krackhardt F, Kreuger Y, Kukreja N, Ladan B, Lantelme P, Leandro S, Leibundgut G, Liebetrau C, Lindeboom W, Macaya Miguel C, Mach F, Magro M, Maillard L, Manavifar N, Mauri L, Mcfadden E, Merkely B, Miyazaki Y, Młodziankowski A, Moccetti T, Modolo R, Möllman H, Morelle J, Moschovitis A, Munndt Ottesen M, Muurling M, Naber CK, Neumann F, Oldroyd K, Ong P, Onuma Y, Palsrok S, Petrov I, Plante S, Prokopczuk J, Rademaker-havinga T, Raffel C, Rensing B, Roffi M, Royaards K, Sabate M, Schächinger V, Seidler T, Serra Peñaranda A, Serruys P, Sikarulidze L, Slagboom T, Soliman OI, Sousa A, Spitzer E, Stables R, Steg G, Steinwender C, Subkovas E, Suryapranata H, Takahashi K, Talwar S, Teiger E, ter Weele A, Teurlings E, Thury A, Tijssen J, Tonev G, Trendafilova-lazarova D, Tumscitz C, Umans V, Ungi I, Valkov V, van der Harst P, van Geuns RJ, van Meijeren C, Vassilev D, Velchev V, Velthuizen E, Verheugt F, Vlcek N, vom Dahl J, Vrolix M, Walsh S, Werner N, Windecker S, Witsenburg M, Zaman A, Żmudka K, Zrenner B, Zurakowski A, Zweiker R. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial. The Lancet 2018;392:940-9. [DOI: 10.1016/s0140-6736(18)31858-0] [Cited by in Crossref: 306] [Cited by in F6Publishing: 66] [Article Influence: 102.0] [Reference Citation Analysis]
22 Picard F, Pighi M, de Hemptinne Q, Airaksinen J, Vinco G, de Pommereau A, Biancari F, Varenne O. Comparison of the biodegradable polymer everolimus-eluting stent with contemporary drug-eluting stents: A systematic review and meta-analysis. International Journal of Cardiology 2019;278:51-6. [DOI: 10.1016/j.ijcard.2018.11.113] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
23 Zhu P, Zhou X, Zhang C, Li H, Zhang Z, Song Z. Safety and efficacy of ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer drug-eluting stents: a meta-analysis of randomized trials. BMC Cardiovasc Disord 2018;18:170. [PMID: 30111289 DOI: 10.1186/s12872-018-0902-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
24 Yasumura K, Shutta R, Matsunaga-Lee Y, Nakamura D, Yano M, Yamato M, Egami Y, Sakata Y, Nishino M, Tanouchi J. Comparison of coronary angioscopic findings 8 months after stent implantation between two kinds of biodegradable polymer-coated and one durable polymer-coated drug-eluting stent. Coron Artery Dis 2021;32:91-5. [PMID: 32976243 DOI: 10.1097/MCA.0000000000000971] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Choe JC, Cha KS, Lee JG, Kim J, Shin JY, Ahn J, Park JS, Lee HW, Oh J, Choi JH, Lee HC, Hong TJ, Jeong MH. Long-Term Outcomes of Biodegradable Versus Second-Generation Durable Polymer Drug-Eluting Stent Implantations for Myocardial Infarction. JACC: Cardiovascular Interventions 2020;13:97-111. [DOI: 10.1016/j.jcin.2019.08.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
26 Will M, Kwok CS, Nagaraja V, Potluri R, Weiss TW, Mascherbauer J, Schwarz K. Outcomes of patients who undergo elective covered stent treatment for coronary artery aneurysms. Cardiovasc Revasc Med 2021:S1553-8389(21)00264-5. [PMID: 34034989 DOI: 10.1016/j.carrev.2021.05.018] [Reference Citation Analysis]
27 Piccirillo F, Caiazzo G, Miglionico M, Nusca A, Melfi R, Gallo P, Ricottini E, De Michele M, Golino L, Manganiello V, Fattore L, Mangiacapra F, Di Sciascio G. REabsorbable vs. DUrable Polymer Drug-Eluting Stents in All-Comer PatiEnts: the REDUCE registry. Coron Artery Dis 2021;32:281-7. [PMID: 33229939 DOI: 10.1097/MCA.0000000000000993] [Reference Citation Analysis]
28 Xu B, Saito Y, Baumbach A, Kelbæk H, van Royen N, Zheng M, Morel M, Knaapen P, Slagboom T, Johnson TW, Vlachojannis G, Arkenbout KE, Holmvang L, Janssens L, Ochala A, Brugaletta S, Naber CK, Anderson R, Rittger H, Berti S, Barbato E, Toth GG, Maillard L, Valina C, Buszman P, Thiele H, Schächinger V, Lansky A, Wijns W. 2-Year Clinical Outcomes of an Abluminal Groove–Filled Biodegradable-Polymer Sirolimus-Eluting Stent Compared With a Durable-Polymer Everolimus-Eluting Stent. JACC: Cardiovascular Interventions 2019;12:1679-87. [DOI: 10.1016/j.jcin.2019.05.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
29 Nogic J, Baey Y, Nerlekar N, Ha FJ, Cameron JD, Nasis A, West NE, Brown AJ. Polymer-free versus permanent polymer-coated drug eluting stents for the treatment of coronary artery disease: A meta-analysis of randomized trials. J Interven Cardiol 2018;31:608-16. [DOI: 10.1111/joic.12522] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
30 Pleva L, Kukla P, Hlinomaz O. Treatment of coronary in-stent restenosis: a systematic review. J Geriatr Cardiol. 2018;15:173-184. [PMID: 29662511 DOI: 10.11909/j.issn.1671-5411.2018.02.007] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
31 Kobayashi T, Sotomi Y, Suzuki S, Hamanaka Y, Nakatani S, Dijkstra J, Onuma Y, Serruys PW, Sakata Y, Hirayama A, Higuchi Y. Neointimal characteristics comparison between biodegradable-polymer and durable-polymer drug-eluting stents: 3-month follow-up optical coherence tomography light property analysis from the RESTORE registry. Int J Cardiovasc Imaging 2020;36:205-15. [DOI: 10.1007/s10554-019-01718-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Iannaccone M, Barbero U, De Benedictis M, Imori Y, Quadri G, Trabattoni D, Ryan N, Venuti G, Montabone A, Wojakowski W, Rognoni A, Helft G, Parma R, De Luca L, Autelli M, Boccuzzi G, Mattesini A, Templin C, Cerrato E, Wańha W, Smolka G, Huczek Z, Tomassini F, Cortese B, Capodanno D, Chieffo A, Nuñez-Gil I, Gili S, Bassignana A, di Mario C, Doronzo B, Omedè P, D'Amico M, Tedeschi D, Varbella F, Luscher T, Sheiban I, Escaned J, Rinaldi M, D'Ascenzo F. Comparison of bioresorbable vs durable polymer drug-eluting stents in unprotected left main (from the RAIN-CARDIOGROUP VII Study). BMC Cardiovasc Disord 2020;20:225. [PMID: 32414330 DOI: 10.1186/s12872-020-01420-5] [Reference Citation Analysis]
33 Linden K, McQuillan C, Brennan P, Menown IBA. Advances in Clinical Cardiology 2018: A Summary of Key Clinical Trials. Adv Ther 2019;36:1549-73. [PMID: 31065993 DOI: 10.1007/s12325-019-00962-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
34 Belardi JA, Lamelas PM. Contemporary stents: Tough to get better. Catheter Cardiovasc Interv 2021;97:1352-3. [PMID: 34107565 DOI: 10.1002/ccd.29763] [Reference Citation Analysis]
35 Zocca P, Kok MM, van der Heijden LC, Danse PW, Schotborgh CE, Scholte M, Hartmann M, Linssen GCM, Doggen CJM, von Birgelen C. High Bleeding Risk Patients Treated with Very Thin-Strut Biodegradable Polymer or Thin-Strut Durable Polymer Drug-Eluting Stents in the BIO-RESORT Trial. Cardiovasc Drugs Ther 2018;32:567-76. [PMID: 30143879 DOI: 10.1007/s10557-018-6823-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
36 Mir T, Shanah L, Ahmad U, Sattar Y, Chokshi B, Aggarwal A, Prakash P, Attique HB, Changal KH, Kumar K, Alraies C, Qureshi WT, Afonso L. Bioresorbable polymer and durable polymer metallic stents in coronary artery disease: a meta-analysis. Expert Rev Cardiovasc Ther 2021;19:445-56. [PMID: 33884943 DOI: 10.1080/14779072.2021.1915769] [Reference Citation Analysis]
37 Milder DA, Kam PC. Perioperative implications of newer generation drug-eluting coronary stents: A narrative review. Anaesth Intensive Care 2021;:310057X20984792. [PMID: 34134534 DOI: 10.1177/0310057X20984792] [Reference Citation Analysis]
38 Kobo O, Saada M, Meisel SR, Hellou E, Frimerman A, Fanne RA, Mohsen J, Danon A, Roguin A. Modern Stents: Where Are We Going? Rambam Maimonides Med J 2020;11. [PMID: 32374258 DOI: 10.5041/RMMJ.10403] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
39 Saito Y, Grubman D, Cristea E, Lansky A. The Firehawk Stent: A Review of a Novel Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent. Cardiology in Review 2020;28:208-12. [DOI: 10.1097/crd.0000000000000298] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
40 Bangalore S. The Elusive Late Benefit of Biodegradable Polymer Drug-Eluting Stents. Circulation 2019;139:334-6. [DOI: 10.1161/circulationaha.118.038378] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 4.5] [Reference Citation Analysis]
41 Sim HW, Thong EH, Djohan AH, Chen JZ, Ser JS, Loh PH, Lee CH, Chan MY, Low AF, Tay EL, Chan KH, Tan HC, Loh JP. Long-term clinical outcomes of biodegradable polymer drug eluting stents versus second-generation durable polymer drug eluting stents for ST-segment elevation myocardial infarction. Cardiovasc Revasc Med 2021:S1553-8389(21)00202-5. [PMID: 33893053 DOI: 10.1016/j.carrev.2021.04.014] [Reference Citation Analysis]
42 Omar WA, Kumbhani DJ. The Current Literature on Bioabsorbable Stents: a Review. Curr Atheroscler Rep 2019;21. [DOI: 10.1007/s11883-019-0816-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
43 Iantorno M, Lipinski MJ, Garcia-garcia HM, Forrestal BJ, Rogers T, Gajanana D, Buchanan KD, Torguson R, Weintraub WS, Waksman R. Meta-Analysis of the Impact of Strut Thickness on Outcomes in Patients With Drug-Eluting Stents in a Coronary Artery. The American Journal of Cardiology 2018;122:1652-60. [DOI: 10.1016/j.amjcard.2018.07.040] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 10.7] [Reference Citation Analysis]
44 Xu L, Gao Z, Song Y, Wang H, Xu J, Jiang P, Jiang L, Tang X, Chen J, Gao L, Song L, Zhang Y, Zhao X, Qiao S, Yang Y, Gao R, Xu B, Yuan J. Impact of unprotected left main percutaneous coronary intervention on long-term clinical outcomes: a large single-center study. Coron Artery Dis 2019;30:249-54. [PMID: 30762624 DOI: 10.1097/MCA.0000000000000725] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Youn YJ, Yoo SY, Lee JW, Ahn SG, Lee SH, Yoon J, Park JH, Choi WG, Cho S, Lim SW, Jang YS, Kwon KH, Lee NH, Doh JH, Kang WC, Jeon DW, Lee BK, Heo JH, Hong BK, Choi HH. Safety and Efficacy of a New Ultrathin Sirolimus-Eluting Stent with Abluminal Biodegradable Polymer in Real-World Practice. Korean Circ J 2020;50:317-27. [PMID: 31960640 DOI: 10.4070/kcj.2019.0258] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
46 Kobayashi T, Sotomi Y, Suzuki S, Suwannasom P, Nakatani S, Morino Y, Ako J, Kozuma K, Hirayama A, Sakata Y, Higuchi Y. Five-year clinical efficacy and safety of contemporary thin-strut biodegradable polymer versus durable polymer drug-eluting stents: a systematic review and meta-analysis of 9 randomized controlled trials. Cardiovasc Interv Ther 2020;35:250-8. [PMID: 31422529 DOI: 10.1007/s12928-019-00613-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
47 Scafa Udriște A, Niculescu AG, Grumezescu AM, Bădilă E. Cardiovascular Stents: A Review of Past, Current, and Emerging Devices. Materials (Basel) 2021;14:2498. [PMID: 34065986 DOI: 10.3390/ma14102498] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
48 Li C, Guan C, Zhang R, Yang Y, Ma C, Li H, Chen S, Han Y, Xu B, Gao R; for the TARGET Investigators. Safety and efficacy of a novel abluminal groove‐filled biodegradable polymer sirolimus‐eluting stent for the treatment of de novo coronary lesions: Final five‐year results of the patient‐level pooled analysis from the TARGET I and TARGET II trials. Catheter Cardiovasc Interv 2019;93:818-24. [DOI: 10.1002/ccd.28051] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
49 Iñiguez A, Chevalier B, Richardt G, Neylon A, Jiménez VA, Kornowski R, Carrie D, Moreno R, Barbato E, Serra-Peñaranda A, Guiducci V, Valdés-Chávarri M, Yajima J, Wijns W, Saito S; CENTURY II study investigators. Comparison of long-term clinical outcomes in multivessel coronary artery disease patients treated either with bioresoarbable polymer sirolimus-eluting stent or permanent polymer everolimus-eluting stent: 5-year results of the CENTURY II randomized clinical trial. Catheter Cardiovasc Interv 2020;95:175-84. [PMID: 31033154 DOI: 10.1002/ccd.28224] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
50 Nojima Y, Adachi H, Ihara M, Kurimoto T, Okayama K, Sakata Y, Nanto S. Impact of different coronary angioscopic findings on arterial healing one year after bioresorbable-polymer and second-generation durable-polymer drug-eluting stent implantation. J Cardiol 2020;76:371-7. [PMID: 32423653 DOI: 10.1016/j.jjcc.2020.03.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
51 Torii S, Jinnouchi H, Sakamoto A, Kutyna M, Cornelissen A, Kuntz S, Guo L, Mori H, Harari E, Paek KH, Fernandez R, Chahal D, Romero ME, Kolodgie FD, Gupta A, Virmani R, Finn AV. Drug-eluting coronary stents: insights from preclinical and pathology studies. Nat Rev Cardiol 2020;17:37-51. [DOI: 10.1038/s41569-019-0234-x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 29] [Article Influence: 24.0] [Reference Citation Analysis]
52 Lipinski MJ, Forrestal BJ, Iantorno M, Torguson R, Waksman R. A comparison of the ultrathin Orsiro Hybrid sirolimus-eluting stent with contemporary drug-eluting stents: A meta-analysis of randomized controlled trials. Cardiovascular Revascularization Medicine 2018;19:5-11. [DOI: 10.1016/j.carrev.2017.11.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
53 Gasior P, Gierlotka M, Szczurek-Katanski K, Osuch M, Gnot R, Hawranek M, Gasior M, Polonski L. Bioresorbable polymer-coated thin strut sirolimus-eluting stent vs durable polymer-coated everolimus-eluting stent in daily clinical practice: Propensity matched one-year results from interventional cardiology network registry. Catheter Cardiovasc Interv 2019;93:E362-8. [PMID: 30298545 DOI: 10.1002/ccd.27919] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
54 Chichareon P, Katagiri Y, Asano T, Takahashi K, Kogame N, Modolo R, Tenekecioglu E, Chang C, Tomaniak M, Kukreja N, Wykrzykowska JJ, Piek JJ, Serruys PW, Onuma Y. Mechanical properties and performances of contemporary drug-eluting stent: focus on the metallic backbone. Expert Review of Medical Devices 2019;16:211-28. [DOI: 10.1080/17434440.2019.1573142] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 8.5] [Reference Citation Analysis]